Who makes Orgalutran®?

Orgalutran® is developed by University Hospital, Ghent.

What development phase is Orgalutran® in?

Orgalutran® is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Orgalutran®

University Hospital, Ghent · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	Orgalutran®
Also known as	ganirelix (Ganirelix Acetate Injection), Ganirelix®
Sponsor	University Hospital, Ghent
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Orgalutran® CI brief — competitive landscape report
Orgalutran® updates RSS · CI watch RSS
University Hospital, Ghent portfolio CI